Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;7(5):843-9.
doi: 10.1161/CIRCHEARTFAILURE.114.001105.

Danon disease: clinical features, evaluation, and management

Affiliations
Review

Danon disease: clinical features, evaluation, and management

Ryan S D'souza et al. Circ Heart Fail. 2014 Sep.
No abstract available

Keywords: cardiomyopathy, dilated; cardiomyopathy, hypertrophic; genetics; glycogen storage disease type IIb; lysosomal-associated membrane protein 2; molecular biology; mutation.

PubMed Disclaimer

Conflict of interest statement

Disclosures

None.

Figures

Figure 1
Figure 1. Histological Images From Skeletal Muscle Biopsy and Endomyocardial Biopsy
Electron microscopy shows intracytoplasmic vacuoles (arrows) containing autophagic material and glycogen in both a) skeletal muscle (Bar 1 μm) and b) endomyocardial tissue biopsy (Bar 1 μm). Reprinted from Taylor et al with permission of the publisher. Copyright © 2007, Nature Publishing Group. Authorization for this adaptation has been obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.
Figure 2
Figure 2. LAMP2 Mutations in Danon Disease
This visual display (not to scale) includes locations of previously reported and novel LAMP2 mutations causing Danon disease. Relative positions of mutations are reflected via arrows and bars (deletion and duplications indicated by bars only). Refer to Supplemental Table 1 for specific mutation information.
Figure 3
Figure 3. Genotype-Phenotype Correlation
Age of first-symptom-onset by gender and mutation type is depicted. Mutation types were used as categories of genotype, while age of symptom onset (usually cardiomyopathy but also included skeletal myopathy) was used as a measure of phenotype severity. The utilization of age of death as a measure of phenotype severity (not shown) displayed similar trends, although not enough cases were present in several mutation categories to assess statistical significance. n = number of Danon disease patients

References

    1. Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH. Lysosomal glycogen storage disease with normal acid maltase. Neurology. 1981;31:51–57. - PubMed
    1. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M. Primary lamp-2 deficiency causes x-linked vacuolar cardiomyopathy and myopathy (danon disease) Nature. 2000;406:906–910. - PubMed
    1. Taylor MR, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, Graw S, Carniel E, Barnes C, Quan D, Prall R, Lovell MA, Mierau G, Ruegg P, Mandava N, Bristow MR, Towbin JA, Mestroni L, Registry FC. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007;52:830–835. - PubMed
    1. Froissart R, Maire I. Danon disease. Orphanet Encyclopedia. 2004 https://www.orpha.net/data/patho/GB/uk-Danon.pdf.
    1. Nishino I. Autophagic vacuolar myopathy. Semin Pediatr Neurol. 2006;13:90–95. - PubMed

Publication types

MeSH terms